Business Context and Reporting Period
This Form 8-K was filed by Aclarion, Inc. on November 27, 2024. The filing reports the entry into a material definitive agreement regarding an amendment to an existing equity line of credit.
Key Financial Metrics and Transaction Details
The filing does not contain standard financial statements (revenue, profit, cash flow, or margins). Key transaction metrics include:
- Equity Line Capacity: Total aggregate gross purchase price of $10,000,000.
- Utilization to Date: $3,216,981 in proceeds received through September 30, 2024.
- Remaining Capacity: Approximately $6.8 million available for future share sales.
- Commitment Shares Issued: 560,915 shares of Common Stock issued to White Lion Capital, LLC as consideration for the amendment.
Material Changes Versus Prior Period
The primary change is the amendment to the Equity Line Purchase Agreement originally dated October 9, 2023. Key modifications include:
- Expiration Extension: The agreement term has been extended from December 31, 2024, to December 31, 2025.
- New Pricing Methods: Two additional purchase notice types were added to the existing five methods (Fixed, Rapid, VWAP):
- Accelerated Purchase Notice: Price based on the lowest traded price in the 15 minutes prior to notice (at 85%), subject to delivery timing conditions.
- Pre-Market Purchase Notice: Price based on the lowest traded price between 12:00 am and 6:30 am Pacific Time on the notice date.
Guidance, Outlook, and Risks
Management Commentary: The filing focuses on the mechanics of the amended agreement and does not provide forward-looking financial guidance or operational outlook.
Risks and Contingencies:
- Unregistered Securities: The Common Stock sold under the agreement has not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption.
- Dilution: The issuance of 560,915 Commitment Shares and potential future issuances under the line will result in shareholder dilution.
- Pricing Volatility: The new pricing mechanisms (Accelerated and Pre-Market) rely on specific time-window trading prices, which may be subject to market volatility.
Important Facts for Investor Verification
- Verify the current market price of Aclarion Common Stock (ACON) to assess the dilution impact of the 560,915 Commitment Shares issued.
- Review the full text of the Equity Line Amendment (Exhibit 10.1) for specific conditions regarding the new pricing methods.
- Monitor future 8-K filings for "Purchase Notices" to track actual utilization of the remaining ~$6.8 million capacity.
- Confirm the company's cash position in subsequent quarterly reports (10-Q) to determine the necessity of drawing down the equity line.